Most recent update: Friday, January 24, 2020 - 11:27

Bariatric News - Cookies & privacy policy

You are here


Hyularonic acid at the gastroesophageal junction

Endoscopic Injection of Hyaluronic Acid at the Gastro Esophageal Junction as an adjuvant to obesity treatments. An ongoing clinical trial.

In 2012, the treatment of morbid obesity entails several surgical procedures, most of them being performed laparoscopically. In order to gain wider acceptance, research for non-invasive techniques is mandatory in this field. The protocol we introduce here has compared a simple and cheap injection device to a bariatric technique, the intra-gastric balloon.

Race is an indicator of weight loss

Two studies presented at the recent ASMBS meeting in San Diego indicate that a patient’s race is a factor affecting weight loss following bariatric surgery.

In a the first study, researchers from the Einstein Healthcare Network in Philadelphia reported that African-Americans and males lost significant weight after gastric bypass surgery, but not as much as their white and female counterparts.

Ten-year trial: bypass beats band

A trial designed to assess outcomes for patients receiving laparoscopic adjustable gastric banding (LAGB) vs. laparoscopic Roux–en-Y gastric bypass (LRYGB) has reported bypass has better weight loss and reduced number of failures, despite significantly longer operative time and life-threatening complications.

Subscribe to RSS - comparison